Basic information Supplier

Bulaquine

Basic information Supplier
79781-00-3 Basic informationMore
USE
Bulaquine is a derivative of primaquine that was introduced in India in combination with chloroquine as a treatment against malaria. The compound is prepared by condensation of primaquine with 3-acetyl-y-butyrolactone in presence of a catalytic amount of base. Bulaquine kills the latent tissue stage (hypnozoites) of the parasite Plasmodium vivax accumulated in the liver and responsible for relapses. Its efficient anti-relapse activity was demonstrated against sporozoite induced Plasmodium cynomolgi infection in rhesus monkey. Bulaquine is safer than primaquine, the preceding candidate against malaria relapse. Although it is stable at pH 7-8, bulaquine is hydrolyzed to primaquine under acidic conditions.

Browse by Nationality 79781-00-3 Suppliers >Global suppliers

Shanghai (1) Sichuan (1) Member (2) All (2)
Please select the suppliers
Recommend You Select Member Companies
  • Company Name:TargetMol Chemicals Inc.
  • Tel: 4008200310
  • Products Intro:Product Name:Bulaquine;Bulaquine
    CAS:79781-00-3
    Purity:98% Package:5 mg
  • CB Index:58
  • Related Information:Catalog(24017)
  •